×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Business Agility: Recognizing Global Business Environment and Appropriate Strategies Adaptations
Session Chair(s)
Lawrence Fine, PhD, MBA
Business Consultant
Lawrence Fine, LLC, United States
The session aims to enhance the participant's ability to recognize the global business environment, focusing on critical factors influencing business strategy. We will illustrate adopting business and regulatory strategies to evolving landscapes.
Learning Objective : Identify key factors and trends influencing the biotechnology and pharmaceutical industries; Evaluate the impact of these trends on business and regulatory strategies; Propose strategic adaptations to address evolving industry and regulatory challenges.
Speaker(s)
Beyond Borders: Impact of Economic Shifts on Regulatory Strategies in Obesity Care
Tetyana Fine, MS
Astrazeneca, United States
Director, Global Regulatory Affairs
Global Strategy Considerations for Biosimilar Approvals
Rosalyn Janine Bailey, MPharm, MS
Syneos Health, United States
Executive Director NA & LATAM Head – Global Regulatory Affairs Solultions
Artificial Intelligence in Drug Development
Darshini Trivedi
Amgen, Inc, United States
Senior Director, Global Regulatory Affairs and Product Strategy
Have an account?